| Expression pattern: |
UP |
| Associated gene: |
GINS4, CDK6, PCNA, Bcl2, Bax, Ki67 |
| Associated microRNA: |
miR-578 |
| Biological function: |
Promotes breast cancer cell growth, proliferation, migration, invasion, angiogenesis and tumor growth, and inhibits apoptosis. |
| Molecular mechanism: |
Hsa_circ_0008673 acts as a miR-578 sponge to positively regulate GINS4 expression, thereby promoting breast cancer progression through the hsa_circ_0008673/miR-578/GINS4 axis. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); angiogenesis (promotes); apoptosis (inhibits); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
Sanger Sequencing; RT-qPCR; Clinical Sample Validation; Transfection; EdU Staining; Transwell Assay; Tube Formation Assay; Annexin V/PI Flow Cytometry; Western Blot; Luciferase Reporter Assay; RNA Pull-Down; In Vivo Animal Model; IHC (Immunohistochemistry); Bioinformatics Analysis |
| Clinical significance: |
The hsa_circ_0008673/miR-578/GINS4 axis may be an important target therapy for breast cancer. |
| Description: |
Hsa_circ_0008673 is up-regulated in breast cancer tissues and cell lines. It functions as an oncogenic circRNA by sponging miR-578 to increase GINS4 expression, thereby promoting breast cancer cell proliferation, migration, invasion, angiogenesis and xenograft tumor growth while suppressing apoptosis. The hsa_circ_0008673/miR-578/GINS4 axis is proposed as a potential therapeutic target for breast cancer. |
| Confidence score: |
0.8005 |